Quadrant Capital »

X4 Pharmaceuticals shares owned by Quadrant Capital

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $528 128 4.13

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Schwab Strategic Tr Fundamental Us L (FNDX)
Amazon (AMZN)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Procter & Gamble Company (PG)

View all positions for Quadrant Capital

Top funds holding X4 Pharmaceuticals

Morgan Stanley
Empery Asset Management
FMR
Bain Capital Life Sciences Investors
Perceptive Advisors
Deep Track Capital
Saturn V Capital Management
Kalehua Capital Management
Vanguard Capital Management
Vanguard Group
Braidwell
Blackstone Group
Rosalind Advisors
Trails Edge Capital Partners
Nantahala Capital Management

View all funds holding X4 Pharmaceuticals